Defining consensus opinion to develop randomised controlled trials in rare diseases using Bayesian design: An example of a proposed trial of adalimumab versus pamidronate for children with CNO/CRMO. (2019)

First Author: Ramanan AV
Attributed to:  Novel model-based designs for early phase trials of medicines for children funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pone.0215739

PubMed Identifier: 31166977

Publication URI: http://europepmc.org/abstract/MED/31166977

Type: Journal Article/Review

Volume: 14

Parent Publication: PloS one

Issue: 6

ISSN: 1932-6203